ARTICLE | Company News
Epizyme, GlaxoSmithKline deal
April 28, 2014 7:00 AM UTC
Epizyme will receive a $4 million milestone payment from GlaxoSmithKline under a 2011 deal in which the companies partnered to discover, develop and commercialize small molecule therapeutics targeting...